miR‑383 increases the cisplatin sensitivity of lung adenocarcinoma cells through inhibition of the RBM24‑mediated NF‑κB signaling pathway
Affiliations: Department of Thoracic Surgery, Southwest Hospital, Army Medical University, Chongqing 400038, P.R. China, The Central Laboratory, Shenzhen Second People's Hospital, Shenzhen University First Affiliated Hospital, Shenzhen, Guangdong 518035, P.R. China, Department of Cardiology, Southwest Hospital, Army Medical University, Chongqing 400038, P.R. China
- Published online on: September 22, 2021 https://doi.org/10.3892/ijo.2021.5267
- Article Number: 87
Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.